DR. ETHAN ALLEN NATELSON, M.D.
Osteopathic Medicine at Fannin St, Houston, TX
License number
Texas D9036
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
Texas D9036
Category
Osteopathic Medicine
Type
Hematology
Address
Address
6550 Fannin St SUITE 1001, Houston, TX 77030
Phone
(713) 441-5154
(713) 771-8844
(713) 771-8844
Personal information
See more information about ETHAN ALLEN NATELSON at radaris.comName
Address
Phone
10511 Ranier Dr, Houston, TX 77031
1919 La Branch St, Houston, TX 77002
8707 Wateka Dr, Houston, TX 77074
8708 Wateka Dr, Houston, TX 77074
Professional information
See more information about ETHAN ALLEN NATELSON at trustoria.com
Dr. Ethan A Natelson, Houston TX - MD (Doctor of Medicine)
Dr. Ethan A Natelson, Houston TX - MD (Doctor of Medicine)
Address:
Methodist Academic Medcn Assocs
6550 Fannin St SUITE 1101, Houston 77030
(713) 441-0006 (Phone)
6550 Fannin St SUITE 1101, Houston 77030
(713) 441-0006 (Phone)
Hospitals:
Methodist Academic Medcn Assocs
6550 Fannin St SUITE 1101, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
6550 Fannin St SUITE 1101, Houston 77030
The Methodist Hospital
6565 Fannin St, Houston 77030
Education:
Medical Schools
Baylor College Of Medicine
Graduated: 1966
Baylor College Of Medicine
Graduated: 1966
Method For Treating Pancreatic Cancer In Humans With Water-Insoluble S-Camptothecin Of The Closed Lactone Ring Form And Derivatives Thereof
Method For Treating Pancreatic Cancer In Humans With Water-Insoluble S-Camptothecin Of The Closed Lactone Ring Form And Derivatives Thereof
US Patent:
6080751, Jun 27, 2000
Filed:
Sep 13, 1996
Appl. No.:
8/713392
Inventors:
John S. Stehlin - Houston TX
Ethan A. Natelson - Houston TX
Beppino C. Giovanella - Houston TX
Anthony J. Kozielski - Houston TX
Ethan A. Natelson - Houston TX
Beppino C. Giovanella - Houston TX
Anthony J. Kozielski - Houston TX
Assignee:
The Stehlin Foundation for Cancer Research - Houston TX
International Classification:
A61K 3144
US Classification:
514283
Abstract:
A method of treating human pancreatic cancer with water-insoluble 20(S)-camptothecin compounds with the closed-lactone ring intact and/or derivatives thereof is disclosed. The method includes preferably administering the compounds intramuscularly, orally, and transdermally.
Ethan Allen Natelson, Houston TX
Ethan Allen Natelson, Houston TX
Specialties:
Hematologist
Address:
1315 St Joseph Pkwy, Houston, TX 77002
6550 Fannin St, Houston, TX 77030
6550 Fannin St, Houston, TX 77030
Education:
Baylor University, College of Medicine - Doctor of Medicine
Baylor Clinic & Hospital - Fellowship - Hematology
Baylor Clinic & Hospital - Residency - Family Medicine
Baylor Clinic & Hospital - Fellowship - Hematology
Baylor Clinic & Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)
Ethan Allen Natelson, Houston TX
Ethan Allen Natelson, Houston TX
Specialties:
Internal Medicine, Hematology, Hematology & Oncology
Work:
The Methodist Hospital
6550 Fannin St, Houston, TX 77030
6550 Fannin St, Houston, TX 77030
Education:
Baylor College of Medicine (1966)
Method For Treating Hematologic Disorders With Water Insoluble 20 (S)-Camptothecin
Method For Treating Hematologic Disorders With Water Insoluble 20 (S)-Camptothecin
US Patent:
2002013, Sep 19, 2002
Filed:
Apr 20, 2000
Appl. No.:
09/556020
Inventors:
Beppino Giovanella - Houston TX, US
Ethan Natelson - Houston TX, US
Ethan Natelson - Houston TX, US
International Classification:
A61F013/00, A61K009/20
US Classification:
424/464000, 424/465000
Abstract:
A method is provided for treating a patient afflicted with a hematologic disorder such as chronic leukemia and the myelodysplastic syndromes. The method includes administering to the patient an effective amount of a water-insoluble 20(S)-camptothecin compound with a closed lactone ring, a derivative thereof, or a mixture thereof. In a preferred method, the compound administered is 9-nitro-20(S)-camptothecin. The compound can be administered orally, intramuscularly, transdermally, subcutaneously, or parenterally.